Under the partnership, Mayo Clinic’s multimodal datasets, laboratories and clinical expertise will combine with Nucleai’s AI platform to develop new offerings for biomarker discovery and validation, end-to-end spatial biology testing and algorithm deployment for clinical trials and diagnostic use, according to a June 4 press release from Nucleai.
The aim is for both entities to create new digital pathology solutions, technologies and services to support drug development and clinical practice.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
